Fibulin-2 Facilitates Malignant Progression of Hepatocellular Carcinoma.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology(2023)

引用 0|浏览3
暂无评分
摘要
Fibulin-2 exhibited tumor promotor activities in malignant progression of hepatocellular carcinoma. The results of the study highlighted the potential of fibulin-2 to be utilized as a promising biomarker and therapeutic target for hepatocellular carcinoma.
更多
查看译文
关键词
Fibulin-2, hepatocellular carcinoma, oncogene, MAPK pathway
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要